Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2364-1746
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review ; volume:8 ; number:1 ; day:3 ; month:2 ; year:2022 ; pages:43-55 ; date:3.2022
Pulmonary therapy ; 8, Heft 1 (3.2.2022), 43-55, 3.2022
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s41030-022-00181-0
- URN
-
urn:nbn:de:101:1-2022052321181608514012
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mirsaeidi, Mehdi
- Baughman, Robert P.
- SpringerLink (Online service)
Other Objects (12)
Repository corticotropin for Chronic Pulmonary Sarcoidosis
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation
Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept
Repository corticotropin for Chronic Pulmonary Sarcoidosis
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation
Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept
Repository corticotropin for Chronic Pulmonary Sarcoidosis
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications
Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation